Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Bennett

Showing results (361-370 of 371) with videos related to

Pageof 38
Sort By:
Transplantation Proceedings|February 1, 1993
Use of OKT4A (a murine monoclonal anti-CD4 antibody) in human organ transplantation: initial clinical experienceD J Norman, W M Bennett, A Cobanoglu, et al.
Kidney International|August 1, 1995
Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicityB A Young, E A Burdmann, R J Johnson, et al.
The American Journal of Medicine|March 1, 1973
The nephropathy of the nail-patella syndrome. Clinicopathologic analysis of 11 kindredW M Bennett, J E Musgrave, R A Campbell, et al.
Clinical Transplants|January 1, 1996
Thirty-seven years of renal transplantation in OregonJ M Barry, M J Lemmers, M J Conlin, et al.
Transplantation|December 1, 1993
Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicityS R Smith, V B Kubacki, A Rakhit, et al.
The Journal of Infectious Diseases|July 1, 1988
The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscessC A Wood, D R Norton, S J Kohlhepp, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1996
Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney FoundationW L Henrich, L E Agodoa, B Barrett, et al.
Clinical Pharmacology and Therapeutics|March 1, 1991
The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: a multicenter studyM Moser, P A Abraham, W M Bennett, et al.
Journal of the American Society of Nephrology : JASN|October 1, 1995
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontinR H Pichler, N Franceschini, B A Young, et al.
Kidney International|December 1, 1996
SPARC is expressed in renal interstitial fibrosis and in renal vascular injuryR H Pichler, C Hugo, S J Shankland, et al.
Pageof 38

Showing results (361-370 of 371) with videos related to

Sort By:
Pageof 38
Transplantation Proceedings|February 1, 1993
Use of OKT4A (a murine monoclonal anti-CD4 antibody) in human organ transplantation: initial clinical experienceD J Norman, W M Bennett, A Cobanoglu, et al.
Kidney International|August 1, 1995
Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicityB A Young, E A Burdmann, R J Johnson, et al.
The American Journal of Medicine|March 1, 1973
The nephropathy of the nail-patella syndrome. Clinicopathologic analysis of 11 kindredW M Bennett, J E Musgrave, R A Campbell, et al.
Clinical Transplants|January 1, 1996
Thirty-seven years of renal transplantation in OregonJ M Barry, M J Lemmers, M J Conlin, et al.
Transplantation|December 1, 1993
Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicityS R Smith, V B Kubacki, A Rakhit, et al.
The Journal of Infectious Diseases|July 1, 1988
The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscessC A Wood, D R Norton, S J Kohlhepp, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1996
Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney FoundationW L Henrich, L E Agodoa, B Barrett, et al.
Clinical Pharmacology and Therapeutics|March 1, 1991
The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: a multicenter studyM Moser, P A Abraham, W M Bennett, et al.
Journal of the American Society of Nephrology : JASN|October 1, 1995
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontinR H Pichler, N Franceschini, B A Young, et al.
Kidney International|December 1, 1996
SPARC is expressed in renal interstitial fibrosis and in renal vascular injuryR H Pichler, C Hugo, S J Shankland, et al.
Pageof 38